Produkty lecznicze - Wykaz pozwoleń na dopuszczenie do obrotu udzielonych przez państwa EOG-EFTA w pierwszym półroczu 2020 r. - Podkomitet I ds. swobodnego przepływu towarów - Do wiadomości Wspólnego Komitetu EOG.
Dz.U.UE.C.2021.39.6
Akt nienormatywnyProdukty lecznicze - Wykaz pozwoleń na dopuszczenie do obrotu udzielonych przez państwa EOG-EFTA w pierwszym półroczu 2020 r.
Podkomitet I ds. swobodnego przepływu towarów Do wiadomości Wspólnego Komitetu EOG
(Dz.U.UE C z dnia 4 lutego 2021 r.)
W nawiązaniu do decyzji Wspólnego Komitetu EOG nr 74/1999 z dnia 28 maja 1999 r. Wspólnemu Komitetowi EOG przekazuje się celem przyjęcia do wiadomości na posiedzeniu w dniu 25 września 2020 r. następujące wykazy dotyczące pozwoleń na dopuszczenie do obrotu produktów leczniczych za okres od dnia 1 stycznia do dnia 30 czerwca 2020 r.
Załącznik I Wykaz nowych pozwoleń na dopuszczenie do obrotu
Załącznik II Wykaz odnowionych pozwoleń na dopuszczenie do obrotu
Załącznik III Wykaz przedłużonych pozwoleń na dopuszczenie do obrotu
Załącznik IV Wykaz wycofanych pozwoleń na dopuszczenie do obrotu
Załącznik V Wykaz zawieszonych pozwoleń na dopuszczenie do obrotu
ZAŁĄCZNIKI
ZAŁĄCZNIK I
Wykaz nowych pozwoleń na dopuszczenie do obrotu
Wykaz nowych pozwoleń na dopuszczenie do obrotu
Numer UE | Produkt | Państwo | Data udzielenia pozwolenia |
EU/1/19/1415 | Amsparity | Islandia | 19.2.2020 |
EU/1/19/1415 | Amsparity | Liechtenstein | 29.2.2020 |
EU/1/19/1415 | Amsparity | Norwegia | 20.2.2020 |
EU/1/20/1427 | Arsenic trioxide Mylan | Islandia | 20.4.2020 |
EU/1/20/1427 | Arsenic trioxide Mylan | Liechtenstein | 30.4.2020 |
EU/1/20/1427 | Arsenic trioxide Mylan | Norwegia | 14.4.2020 |
EU/2/19/249 | Aservo EquiHaler | Islandia | 18.2.2020 |
EU/2/19/249 | Aservo EquiHaler | Liechtenstein | 29.2.2020 |
EU/2/19/249 | Aservo EquiHaler | Norwegia | 5.3.2020 |
EU/1/20/1439 | Atectura Breezhaler | Islandia | 23.6.2020 |
EU/1/20/1439 | Atectura Breezhaler | Liechtenstein | 30.6.2020 |
EU/1/20/1439 | Atectura Breezhaler | Norwegia | 8.6.2020 |
EU/1/19/1413 | Azacitidine Accord | Islandia | 19.2.2020 |
EU/1/19/1413 | Azacitidine Accord | Liechtenstein | 29.2.2020 |
EU/1/19/1413 | Azacitidine Accord | Norwegia | 21.2.2020 |
EU/1/19/1416 | Azacitidine Betapharm | Islandia | 16.4.2020 |
EU/1/19/1416 | Azacitidine Betapharm | Liechtenstein | 30.4.2020 |
EU/1/19/1416 | Azacitidine Betapharm | Norwegia | 31.3.2020 |
EU/1/20/1426 | Azacitidine Mylan | Islandia | 17.4.2020 |
EU/1/20/1426 | Azacitidine Mylan | Liechtenstein | 30.4.2020 |
EU/1/20/1426 | Azacitidine Mylan | Norwegia | 2.4.2020 |
EU/1/19/1406 | Baqsimi | Norwegia | 13.1.2020 |
EU/1/20/1441 | Bemrist Breezhaler | Islandia | 22.6.2020 |
EU/1/20/1441 | Bemrist Breezhaler | Liechtenstein | 30.6.2020 |
EU/1/20/1441 | Bemrist Breezhaler | Norwegia | 8.6.2020 |
EU/1/19/1417 | Beovu | Islandia | 18.2.2020 |
EU/1/19/1417 | Beovu | Liechtenstein | 29.2.2020 |
EU/1/19/1417 | Beovu | Norwegia | 19.2.2020 |
EU/1/19/1403 | Budesonide/Formoterol Teva Pharma B.V. | Islandia | 22.5.2020 |
EU/1/19/1403 | Budesonide/Formoterol Teva Pharma B.V. | Liechtenstein | 30.4.2020 |
EU/1/19/1403 | Budesonide/Formoterol Teva Pharma B.V. | Norwegia | 14.4.2020 |
EU/1/19/1409 | Cegfila | Islandia | 9.1.2020 |
EU/1/20/1429 | Cinacalcet Accordpharma | Islandia | 21.4.2020 |
EU/1/20/1429 | Cinacalcet Accordpharma | Norwegia | 14.4.2020 |
EU/1/19/1395 | Clopidogrel/Acetylsalicylic acid Mylan | Islandia | 20.1.2020 |
EU/1/19/1395 | Clopidogrel/Acetylsalicylic acid Mylan | Norwegia | 7.2.2020 |
EU/1/20/1451 | Daurismo | Liechtenstein | 30.6.2020 |
EU/1/19/1412 | Deferasirox Accord | Islandia | 15.1.2020 |
EU/1/19/1412 | Deferasirox Accord | Norwegia | 22.1.2020 |
EU/1/19/1418 | Dexmedetomidin Accord | Islandia | 18.2.2020 |
EU/1/19/1418 | Dexmedetomidin Accord | Liechtenstein | 29.2.2020 |
EU/1/19/1418 | Dexmedetomidin Accord | Norwegia | 19.2.2020 |
EU/1/19/1411 | Evenity | Norwegia | 3.1.2020 |
EU/1/20/1434 | Fetcroja | Islandia | 19.5.2020 |
EU/1/20/1434 | Fetcroja | Liechtenstein | 30.4.2020 |
EU/1/20/1434 | Fetcroja | Norwegia | 8.5.2020 |
EU/1/20/1450 | Fingolimod Accord | Liechtenstein | 30.6.2020 |
EU/1/20/1433 | Fluad Tetra | Islandia | 16.6.2020 |
EU/1/20/1433 | Fluad Tetra | Liechtenstein | 30.6.2020 |
EU/1/20/1433 | Fluad Tetra | Norwegia | 2.6.2020 |
EU/1/20/1428 | Givlaari | Islandia | 20.3.2020 |
EU/1/20/1428 | Givlaari | Liechtenstein | 30.4.2020 |
EU/1/20/1428 | Givlaari | Norwegia | 6.3.2020 |
EU/2/19/245 | Gumbohatch | Norwegia | 29.6.2020 |
EU/1/20/1447 | Insulin aspart Sanofi | Liechtenstein | 30.6.2020 |
EU/1/19/1407 | Isturisa | Liechtenstein | 29.2.2020 |
EU/1/19/1407 | Isturisa | Islandia | 16.1.2020 |
EU/1/19/1407 | Isturisa | Liechtenstein | 30.4.2020 |
EU/1/19/1407 | Isturisa | Norwegia | 3.2.2020 |
EU/1/20/1422 | Liumjev | Islandia | 17.4.2020 |
EU/1/20/1422 | Liumjev | Liechtenstein | 30.4.2020 |
EU/1/20/1422 | Liumjev | Norwegia | 31.3.2020 |
EU/2/20/253 | Lydaxx | Islandia | 2.6.2020 |
EU/2/20/253 | Lydaxx | Norwegia | 9.6.2020 |
EU/1/19/1414 | Mayzent | Islandia | 21.2.2020 |
EU/1/19/1414 | Mayzent | Liechtenstein | 29.2.2020 |
EU/1/19/1414 | Mayzent | Norwegia | 27.1.2020 |
EU/1/20/1436 | Nepexto | Islandia | 16.6.2020 |
EU/1/20/1436 | Nepexto | Liechtenstein | 30.6.2020 |
EU/1/20/1436 | Nepexto | Norwegia | 9.6.2020 |
EU/2/19/246 | Neptra | Norwegia | 6.1.2020 |
EU/1/20/1425 | Nilemdo | Islandia | 20.4.2020 |
EU/1/20/1425 | Nilemdo | Liechtenstein | 30.4.2020 |
EU/1/20/1425 | Nilemdo | Norwegia | 15.4.2020 |
EU/1/20/1432 | Nubeqa | Islandia | 17.4.2020 |
EU/1/20/1432 | Nubeqa | Liechtenstein | 30.4.2020 |
EU/1/20/1432 | Nubeqa | Norwegia | 1.4.2020 |
EU/1/20/1424 | Nustendi | Islandia | 17.4.2020 |
EU/1/20/1424 | Nustendi | Norwegia | 3.4.2020 |
EU/1/20/1453 | Paliperidone Janssen-Cilag International | Islandia | 26.6.2020 |
EU/1/20/1453 | Paliperidone Janssen-Cilag International | Liechtenstein | 30.6.2020 |
EU/1/20/1453 | Paliperidone Janssen-Cilag International | Norwegia | 29.6.2020 |
EU/1/19/1409 | Pegfilgrastim Mundipharma | Norwegia | 9.1.2020 |
EU/1/19/1388 | Polivy | Islandia | 24.1.2020 |
EU/1/19/1388 | Polivy | Liechtenstein | 29.2.2020 |
EU/1/19/1388 | Polivy | Norwegia | 27.1.2020 |
EU/1/19/1393 | Quofenix | Norwegia | 9.1.2020 |
EU/1/20/1452 | Reblozyl | Liechtenstein | 30.6.2020 |
EU/1/19/1420 | Recarbrio | Islandia | 18.2.2020 |
EU/1/19/1420 | Recarbrio | Liechtenstein | 29.2.2020 |
EU/1/19/1420 | Recarbrio | Liechtenstein | 30.4.2020 |
EU/1/19/1420 | Recarbrio | Norwegia | 19.2.2020 |
EU/1/19/1420 | Recarbrio | Norwegia | 23.4.2020 |
EU/1/20/1430 | Rybelsus | Liechtenstein | 30.4.2020 |
EU/1/19/1404 | Rinvoq | Norwegia | 3.1.2020 |
EU/1/20/1431 | Ruxience | Islandia | 20.4.2020 |
EU/1/20/1431 | Ruxience | Norwegia | 14.4.2020 |
EU/1/20/1430 | Rybelsus | Islandia | 22.4.2020 |
EU/1/20/1430 | Rybelsus | Norwegia | 14.4.2020 |
EU/1/20/1435 | Sarclisa | Islandia | 23.6.2020 |
EU/1/20/1435 | Sarclisa | Norwegia | 12.6.2020 |
EU/1/19/1387 | Senstend | Liechtenstein | 29.2.2020 |
EU/1/19/1410 | Spravato | Islandia | 3.1.2020 |
EU/1/19/1410 | Spravato | Norwegia | 15.1.2020 |
EU/1/19/1421 | Staquis | Islandia | 20.4.2020 |
EU/1/19/1421 | Staquis | Norwegia | 3.4.2020 |
EU/2/19/248 | Stelfonta | Islandia | 20.2.2020 |
EU/2/19/248 | Stelfonta | Liechtenstein | 29.2.2020 |
EU/2/19/248 | Stelfonta | Norwegia | 30.1.2020 |
EU/1/19/1408 | Sunosi | Islandia | 24.1.2020 |
EU/1/19/1408 | Sunosi | Liechtenstein | 29.2.2020 |
EU/1/19/1408 | Sunosi | Norwegia | 27.1.2020 |
EU/1/19/1405 | Tavlesse | Islandia | 15.1.2020 |
EU/1/19/1405 | Tavlesse | Liechtenstein | 29.2.2020 |
EU/1/19/1405 | Tavlesse | Norwegia | 7.2.2020 |
EU/1/19/1394 | Tigecycline Accord | Islandia | 29.4.2020 |
EU/1/19/1394 | Tigecycline Accord | Liechtenstein | 30.4.2020 |
EU/1/19/1394 | Tigecycline Accord | Norwegia | 17.4.2020 |
EU/1/19/1419 | Trepulmix | Islandia | 21.4.2020 |
EU/1/19/1419 | Trepulmix | Liechtenstein | 30.4.2020 |
EU/1/19/1419 | Trepulmix | Norwegia | 14.4.2020 |
EU/2/20/251 | Tulaven | Islandia | 29.4.2020 |
EU/2/20/251 | Tulaven | Liechtenstein | 30.4.2020 |
EU/2/20/251 | Tulaven | Norwegia | 29.4.2020 |
EU/2/20/252 | TULISSIN | Islandia | 19.5.2020 |
EU/1/18/1309 | Ulipristal Acetate Gedeon Richter | Liechtenstein | 30.4.2020 |
EU/1/20/1423 | Vaxchora | Islandia | 21.4.2020 |
EU/1/20/1423 | Vaxchora | Liechtenstein | 30.4.2020 |
EU/1/20/1423 | Vaxchora | Norwegia | 17.4.2020 |
EU/2/20/250 | Vectormune FP ILT + AE | Islandia | 29.4.2020 |
EU/2/20/250 | Vectormune FP ILT + AE | Liechtenstein | 30.4.2020 |
EU/2/20/250 | Vectormune FP ILT + AE | Norwegia | 29.4.2020 |
EU/1/19/1399 | Xospata | Liechtenstein | 29.2.2020 |
EU/1/20/1442 | Zeposia | Islandia | 22.6.2020 |
EU/1/20/1442 | Zeposia | Liechtenstein | 30.6.2020 |
EU/1/20/1442 | Zeposia | Norwegia | 15.6.2020 |
EU/1/20/1443 | Zolgensma | Islandia | 20.5.2020 |
EU/1/20/1443 | Zolgensma | Liechtenstein | 30.6.2020 |
EU/1/20/1443 | Zolgensma | Norwegia | 20.5.2020 |
ZAŁĄCZNIK II
Wykaz odnowionych pozwoleń na dopuszczenie do obrotu
Wykaz odnowionych pozwoleń na dopuszczenie do obrotu
Numer UE | Produkt | Państwo | Data udzielenia pozwolenia | ||||
EU/1/15/1001 | Akynzeo | Islandia | 15.1.2020 | ||||
EU/1/15/1001 | Akynzeo | Liechtenstein | 29.2.2020 | ||||
EU/1/15/1001 | Akynzeo | Norwegia | 22.1.2020 | ||||
EU/1/15/1005 | Aripiprazole Mylan Pharma | Islandia | 13.3.2020 | ||||
EU/1/15/1005 | Aripiprazole Mylan Pharma | Norwegia | 10.3.2020 | ||||
EU/1/15/1029 | Aripiprazole Sandoz | Liechtenstein | 30.6.2020 | ||||
EU/1/15/1009 | Aripiprazole Zentiva | Islandia | 22.6.2020 | ||||
EU/1/15/1009 | Aripiprazole Zentiva | Liechtenstein | 30.6.2020 | ||||
EU/1/15/1009 | Aripiprazole Zentiva | Norwegia | 18.6.2020 | ||||
EU/1/15/1019 | Bortezomib Accord | Islandia | 20.5.2020 | ||||
EU/1/15/1019 | Bortezomib Accord | Liechtenstein | 30.6.2020 | ||||
EU/1/15/1019 | Bortezomib Accord | Norwegia | 15.5.2020 | ||||
EU/1/13/818 | Bosulif | Islandia | 27.2.2020 | ||||
EU/1/13/818 | Bosulif | Liechtenstein | 29.2.2020 | ||||
EU/1/13/818 | Bosulif | Norwegia | 25.2.2020 | ||||
EU/1/10/645 | Brinavess | Islandia | 22.6.2020 | ||||
EU/1/10/645 | Brinavess | Liechtenstein | 30.6.2020 | ||||
EU/1/10/645 | Brinavess | Norwegia | 8.6.2020 | ||||
EU/2/15/183 | Canigen L4 | Liechtenstein | 30.4.2020 | ||||
EU/2/15/183 | Canigen L4 | Norwegia | 28.4.2020 | ||||
EU/1/11/749 | Caprelsa | Islandia | 21.1.2020 | ||||
EU/1/11/749 | Caprelsa | Liechtenstein | 29.2.2020 | ||||
EU/1/11/749 | Caprelsa | Norwegia | 23.1.2020 | ||||
EU/1/14/974 | Cerdelga | Norwegia | 3.1.2020 | ||||
EU/2/14/180 | Coliprotec F4 | Islandia | 24.1.2020 | ||||
EU/2/14/180 | Coliprotec F4 | Liechtenstein | 29.2.2020 | ||||
EU/2/14/180 | Coliprotec F4 | Norwegia | 12.2.2020 | ||||
EU/1/13/890 | Cometriq | Islandia | 20.3.2020 | ||||
EU/1/13/890 | Cometriq | Liechtenstein | 29.2.2020 | ||||
EU/1/13/890 | Cometriq | Liechtenstein | 30.4.2020 | ||||
EU/1/13/890 | Cometriq | Norwegia | 10.3.2020 | ||||
EU/1/15/1048 | Cotellic | Liechtenstein | 30.6.2020 | ||||
EU/1/17/1262 | Crysvita | Norwegia | 20.1.2020 | ||||
EU/1/10/636 | Daxas | Islandia | 2.6.2020 | ||||
EU/1/10/636 | Daxas | Liechtenstein | 30.6.2020 | ||||
EU/1/10/636 | Daxas | Norwegia | 3.6.2020 | ||||
EU/1/13/875 | Deltyba | Islandia | 19.5.2020 | ||||
EU/1/13/875 | Deltyba | Liechtenstein | 30.4.2020 | ||||
EU/1/13/875 | Deltyba | Norwegia | 30.4.2020 | ||||
EU/1/15/1010 | Duloxetine Mylan | Islandia | 27.2.2020 | ||||
EU/1/15/1010 | Duloxetine Mylan | Liechtenstein | 29.2.2020 | ||||
EU/1/15/1010 | Duloxetine Mylan | Norwegia | 24.2.2020 | ||||
EU/1/15/1025 | Evotaz | Norwegia | 8.4.2020 | ||||
EU/1/15/1058 | Entresto | Liechtenstein | 30.6.2020 | ||||
EU/1/15/1023 | Farydak | Islandia | 22.5.2020 | ||||
EU/1/15/1023 | Farydak | Liechtenstein | 30.4.2020 | ||||
EU/1/15/1023 | Farydak | Norwegia | 7.5.2020 | ||||
EU/1/15/1007 | Gardasil 9 | Islandia | 23.1.2020 | ||||
EU/1/15/1007 | Gardasil 9 | Liechtenstein | 29.2.2020 | ||||
EU/1/15/1007 | Gardasil 9 | Norwegia | 23.1.2020 | ||||
EU/1/14/987 | Holoclar | Islandia | 13.3.2020 | ||||
EU/1/14/987 | Holoclar | Liechtenstein | 30.4.2020 | ||||
EU/1/14/987 | Holoclar | Norwegia | 16.3.2020 | ||||
EU/1/15/990 | Ikervis | Islandia | 13.3.2020 | ||||
EU/2/15/182 | Innovax-ILT | Islandia | 30.4.2020 | ||||
EU/2/15/182 | Innovax-ILT | Liechtenstein | 30.4.2020 | ||||
EU/2/15/182 | Innovax-ILT | Norwegia | 5.5.2020 | ||||
EU/1/15/1041 | Ivabradine Anpharm | Norwegia | 2.6.2020 | ||||
EU/1/15/1040 | Intuniv | Liechtenstein | 30.6.2020 | ||||
EU/1/15/1000 | Jinarc | Islandia | 22.5.2020 | ||||
EU/1/15/1000 | Jinarc | Liechtenstein | 30.4.2020 | ||||
EU/1/15/1000 | Jinarc | Norwegia | 14.4.2020 | ||||
EU/1/15/1033 | Kanuma | Islandia | 22.5.2020 | ||||
EU/1/15/1033 | Kanuma | Liechtenstein | 30.4.2020 | ||||
EU/1/15/1033 | Kanuma | Norwegia | 23.4.2020 | ||||
EU/1/15/994 | Kengrexal | Norwegia | 13.1.2020 | ||||
EU/1/15/1024 | Keytruda | Islandia | 16.4.2020 | ||||
EU/1/15/1024 | Keytruda | Norwegia | 2.4.2020 | ||||
EU/1/15/1060 | Kyprolis | Liechtenstein | 30.6.2020 | ||||
EU/1/15/1002 | Lenvima | Islandia | 3.6.2020 | ||||
EU/1/15/1002 | Lenvima | Liechtenstein | 30.6.2020 | ||||
EU/1/15/1002 | Lenvima | Norwegia | 2.6.2020 | ||||
EU/1/19/1376 | Libtayo | Islandia | 2.6.2020 | ||||
EU/1/19/1376 | Libtayo | Liechtenstein | 30.6.2020 | ||||
EU/1/19/1376 | Libtayo | Norwegia | 2.6.2020 | ||||
EU/1/15/993 | Lixiana | Islandia | 13.3.2020 | ||||
EU/1/15/993 | Lixiana | Norwegia | 10.3.2020 | ||||
EU/1/19/1355 | Lorviqua | Islandia | 19.5.2020 | ||||
EU/1/19/1355 | Lorviqua | Norwegia | 16.4.2020 | ||||
EU/1/15/1013 | Lumark | Islandia | 19.5.2020 | ||||
EU/1/15/1013 | Lumark | Liechtenstein | 30.4.2020 | ||||
EU/1/15/1013 | Lumark | Norwegia | 5.5.2020 | ||||
EU/1/14/988 | Mysimba | Islandia | 23.1.2020 | ||||
EU/1/14/988 | Mysimba | Liechtenstein | 29.2.2020 | ||||
EU/1/14/988 | Mysimba | Norwegia | 23.1.2020 | ||||
EU/1/15/1078 | Natpar | Islandia | 24.6.2020 | ||||
EU/1/15/1078 | Natpar | Liechtenstein | 30.4.2020 | ||||
EU/2/15/186 | Novaquin | Liechtenstein | 30.6.2020 | ||||
EU/1/16/1139 | Ocaliva | Islandia | 20.5.2020 | ||||
EU/1/16/1139 | Ocaliva | Liechtenstein | 30.4.2020 | ||||
EU/1/16/1139 | Ocaliva | Norwegia | 12.5.2020 | ||||
EU/1/15/1030 | Odomzo | Islandia | 16.6.2020 | ||||
EU/1/15/1030 | Odomzo | Liechtenstein | 30.6.2020 | ||||
EU/1/15/1030 | Odomzo | Norwegia | 3.6.2020 | ||||
EU/1/18/1345 | Ondexxya | Islandia | 25.5.2020 | ||||
EU/1/18/1345 | Ondexxya | Liechtenstein | 30.4.2020 | ||||
EU/1/15/1014 | Opdivo | Islandia | 19.5.2020 | ||||
EU/1/15/1014 | Opdivo | Liechtenstein | 30.4.2020 | ||||
EU/1/15/1014 | Opdivo | Norwegia | 8.5.2020 | ||||
EU/1/15/989 | Orbactiv | Islandia | 21.1.2020 | ||||
EU/1/15/989 | Orbactiv | Liechtenstein | 29.2.2020 | ||||
EU/1/15/989 | Orbactiv | Norwegia | 22.1.2020 | ||||
EU/1/16/1089 | Szczepionka przeciw grypie pandemicznej H5N1 AstraZeneca | Islandia | 20.3.2020 | ||||
EU/1/16/1089 | Szczepionka przeciw grypie pandemicznej H5N1 AstraZeneca | Liechtenstein | 29.2.2020 | ||||
EU/1/16/1089 | Szczepionka przeciw grypie pandemicznej H5N1 AstraZeneca | Liechtenstein | 30.4.2020 | ||||
EU/1/16/1089 | Szczepionka przeciw grypie pandemicznej H5N1 AstraZeneca | Norwegia | 24.3.2020 | ||||
EU/1/15/1034 | Pemetrexed Lilly | Islandia | 22.6.2020 | ||||
EU/1/15/1034 | Pemetrexed Lilly | Liechtenstein | 30.6.2020 | ||||
EU/1/15/1034 | Pemetrexed Lilly | Norwegia | 15.6.2020 | ||||
EU/2/15/187 | Porcilis PCV ID | Islandia | 22.6.2020 | ||||
EU/2/15/187 | Porcilis PCV ID | Liechtenstein | 30.6.2020 | ||||
EU/1/15/1031 | Praluent | Islandia | 23.6.2020 | ||||
EU/1/15/1031 | Praluent | Liechtenstein | 30.6.2020 | ||||
EU/1/15/1031 | Praluent | Norwegia | 18.6.2020 | ||||
EU/1/15/997 | Pregabalin Mylan | Islandia | 16.4.2020 | ||||
EU/1/15/997 | Pregabalin Mylan | Liechtenstein | 30.4.2020 | ||||
EU/1/15/997 | Pregabalin Mylan | Norwegia | 16.4.2020 | ||||
EU/1/15/998 | Pregabalin Mylan Pharma | Islandia | 22.5.2020 | ||||
EU/1/15/998 | Pregabalin Mylan Pharma | Liechtenstein | 30.4.2020 | ||||
EU/1/15/998 | Pregabalin Mylan Pharma | Norwegia | 16.4.2020 | ||||
EU/1/14/916 | Pregabalin Pfizer | Norwegia | 10.6.2020 | ||||
EU/1/15/1011 | Pregabalin Sandoz | Liechtenstein | 30.6.2020 | ||||
EU/1/15/1012 | Pregabalin Sandoz GmbH | Liechtenstein | 30.6.2020 | ||||
EU/1/15/1021 | Pregabalin Zentiva | Islandia | 16.6.2020 | ||||
EU/1/15/1021 | Pregabalin Zentiva | Liechtenstein | 30.6.2020 | ||||
EU/1/15/1021 | Pregabalin Zentiva | Norwegia | 2.6.2020 | ||||
EU/2/15/187 | Porcilis PCV ID | Norwegia | 9.6.2020 | ||||
EU/1/10/618 | Prolia | Islandia | 23.1.2020 | ||||
EU/1/10/618 | Prolia | Liechtenstein | 29.2.2020 | ||||
EU/1/14/973 | Quinsair | Islandia | 19.2.2020 | ||||
EU/1/14/973 | Quinsair | Liechtenstein | 29.2.2020 | ||||
EU/1/14/973 | Quinsair | Norwegia | 19.2.2020 | ||||
EU/1/15/1016 | Repatha | Islandia | 22.4.2020 | ||||
EU/1/15/1016 | Repatha | Liechtenstein | 30.4.2020 | ||||
EU/1/15/1016 | Repatha | Norwegia | 22.4.2020 | ||||
EU/1/15/1006 | Respreeza | Islandia | 22.5.2020 | ||||
EU/1/15/1006 | Respreeza | Liechtenstein | 30.4.2020 | ||||
EU/1/15/1006 | Respreeza | Norwegia | 28.4.2020 | ||||
EU/1/17/1250 | Rubraca | Islandia | 22.5.2020 | ||||
EU/1/17/1250 | Rubraca | Liechtenstein | 30.4.2020 | ||||
EU/1/17/1250 | Rubraca | Norwegia | 23.4.2020 | ||||
EU/1/15/992 | Saxenda | Norwegia | 3.1.2020 | ||||
EU/2/15/181 | Sileo | Islandia | 19.5.2020 | ||||
EU/2/15/181 | Sileo | Liechtenstein | 30.4.2020 | ||||
EU/2/15/181 | Sileo | Norwegia | 12.5.2020 | ||||
EU/1/13/901 | Sirturo | Islandia | 15.1.2020 | ||||
EU/1/13/901 | Sirturo | Liechtenstein | 29.2.2020 | ||||
EU/1/13/901 | Sirturo | Norwegia | 23.1.2020 | ||||
EU/1/15/991 | Sivextro | Islandia | 15.1.2020 | ||||
EU/1/15/991 | Sivextro | Liechtenstein | 29.2.2020 | ||||
EU/1/15/991 | Sivextro | Norwegia | 22.1.2020 | ||||
EU/1/15/1015 | Strensiq | Islandia | 20.5.2020 | ||||
EU/1/15/1015 | Strensiq | Norwegia | 5.5.2020 | ||||
EU/1/15/1003 | Synjardy | Islandia | 16.4.2020 | ||||
EU/1/15/1003 | Synjardy | Liechtenstein | 30.4.2020 | ||||
EU/1/15/1003 | Synjardy | Norwegia | 14.4.2020 | ||||
EU/1/15/1004 | Voriconazole Hikma | Islandia | 25.5.2020 | ||||
EU/1/15/1004 | Voriconazole Hikma | Norwegia | 24.3.2020 | ||||
EU/1/19/1360 | Waylivra | Islandia | 21.3.2020 | ||||
EU/1/19/1360 | Waylivra | Liechtenstein | 30.4.2020 | ||||
EU/1/19/1360 | Waylivra | Norwegia | 26.5.2020 | ||||
EU/1/15/1032 | Zerbaxa | Islandia | 30.4.2020 | ||||
EU/1/15/1032 | Zerbaxa | Liechtenstein | 30.4.2020 | ||||
EU/1/15/1032 | Zerbaxa | Norwegia | 28.4.2020 | ||||
EU/2/14/178 | Zulvac SBV | Islandia | 21.1.2020 | ||||
EU/2/14/178 | Zulvac SBV | Liechtenstein | 29.2.2020 | ||||
EU/2/14/178 | Zulvac SBV | Norwegia | 12.2.2020 | ||||
EU/1/19/1367 | Zynteglo | Islandia | 22.5.2020 | ||||
EU/1/19/1367 | Zynteglo | Liechtenstein | 30.4.2020 | ||||
EU/1/19/1367 | Zynteglo | Norwegia | 11.5.2020 |
ZAŁĄCZNIK III
Wykaz przedłużonych pozwoleń na dopuszczenie do obrotu
Wykaz przedłużonych pozwoleń na dopuszczenie do obrotu
Numer UE | Produkt | Państwo | Data udzielenia pozwolenia |
EU/1/15/1001/003 | Akynzeo | Islandia | 16.4.2020 |
EU/1/15/1001/003 | Akynzeo | Norwegia | 23.3.2020 |
EU/1/16/1101/004 | Darzalex | Islandia | 23.6.2020 |
EU/1/11/733/005 | Dificlir | Islandia | 20.3.2020 |
EU/1/11/733/005 | Dificlir | Norwegia | 20.2.2020 |
EU/1/14/923/002-007 | Entyvio | Islandia | 24.6.2020 |
EU/1/14/923/002-007 | Entyvio | Norwegia | 28.4.2020 |
EU/1/18/1288/007 | Halimatoz | Islandia | 20.4.2020 |
EU/1/18/1287/007 | Hefiya | Islandia | 20.4.2020 |
EU/1/18/1286/007 | Hyrimoz | Islandia | 20.4.2020 |
EU/1/16/1147/010-018 | Ibrance | Islandia | 22.4.2020 |
EU/1/16/1147/010-015 | Ibrance | Norwegia | 19.2.2020 |
EU/1/17/1254/007-011 | Jorveza | Islandia | 16.6.2020 |
EU/1/17/1254/007-011 | Jorveza | Norwegia | 2.6.2020 |
EU/1/12/782/006 | Kalydeco | Islandia | 2.1.2020 |
EU/1/16/1115/003-005 | Pemetrexed Fresenius Kabi | Islandia | 19.2.2020 |
EU/1/16/1115/003-005 | Pemetrexed Fresenius Kabi | Norwegia | 19.2.2020 |
EU/1/11/717/003-004 | Vyndaqel | Islandia | 22.4.2020 |
EU/1/11/717/003-004 | Vyndaqel | Norwegia | 24.2.2020 |
EU/1/17/1178/010-013 | XELJANZ | Islandia | 2.1.2020 |
ZAŁĄCZNIK IV
Wykaz wycofanych pozwoleń na dopuszczenie do obrotu
Wykaz wycofanych pozwoleń na dopuszczenie do obrotu
Numer UE | Produkt | Państwo | Data wycofania |
EU/1/09/541 | Clopidogrel ratiopharm GmbH | Islandia | 23.1.2020 |
EU/1/09/541 | Clopidogrel ratiopharm GmbH | Liechtenstein | 29.2.2020 |
EU/1/09/541 | Clopidogrel ratiopharm GmbH | Norwegia | 13.1.2020 |
EU/1/09/510 | Fertavid | Islandia | 30.1.2020 |
EU/1/09/510 | Fertavid | Norwegia | 23.1.2020 |
EU/1/15/1039 | Fexeric | Islandia | 27.2.2020 |
EU/1/00/144 | Helixate NexGen | Islandia | 3.1.2020 |
EU/1/19/1357 | KROMEYA | Islandia | 3.1.2020 |
EU/1/16/1165 | Lifmior | Islandia | 27.2.2020 |
EU/1/04/287 | Osseor | Islandia | 22.5.2020 |
EU/1/04/287 | Osseor | Norwegia | 8.5.2020 |
EU/1/12/796 | Picato | Islandia | 20.2.2020 |
EU/1/12/796 | Picato | Liechtenstein | 29.2.2020 |
EU/1/12/796 | Picato | Norwegia | 11.2.2020 |
EU/1/04/288 | Protelos | Islandia | 22.5.2020 |
EU/1/04/288 | Protelos | Norwegia | 8.5.2020 |
EU/2/09/099 | Suvaxyn PCV | Norwegia | 28.4.2020 |
EU/1/17/1180 | Varuby | Islandia | 30.1.2020 |
EU/1/17/1180 | Varuby | Norwegia | 23.1.2020 |
EU/1/11/671 | Xiapex | Islandia | 6.1.2020 |
EU/1/96/009 | Zerit | Liechtenstein | 30.6.2020 |
EU/2/11/130 | Zulvac 1 Bovis | Islandia | 20.3.2020 |
EU/2/11/130 | Zulvac 1 Bovis | Norwegia | 18.2.2020 |
EU/2/11/131 | Zulvac 1 Ovis | Islandia | 20.3.2020 |
EU/2/11/131 | Zulvac 1 Ovis | Norwegia | 13.3.2020 |
ZAŁĄCZNIK V
Wykaz zawieszonych pozwoleń na dopuszczenie do obrotu
Wykaz zawieszonych pozwoleń na dopuszczenie do obrotu
Numer UE | Produkt | Państwo | Data zawieszenia |
EU/1/12/750 | Esmya | Norwegia | 2.4.2020 |
EU/1/12/796 | Picato | Norwegia | 22.1.2020 |
EU/1/18/1309 | Ulipristal Acetate Richter | Norwegia | 28.5.2020 |
© Unia Europejska, http://eur-lex.europa.eu/
Za autentyczne uważa się wyłącznie dokumenty Unii Europejskiej opublikowane w Dzienniku Urzędowym Unii Europejskiej.